Kid PROOF Act of 2025

The Kid PROOF Act of 2025, HR6396, was introduced in the House on December 3, 2025, and subsequently referred to the Committee on Energy and Commerce and the Committee on Education and Workforce. This indicates the bill is in the early stages of the legislative process. The bill's primary purpose is to amend the SUPPORT for Patients and Communities Act to authorize the use of existing grants for preventing suicide and overdose among children, adolescents, and young adults. It also expands the types of entities eligible to receive these grants to include specialized pediatric and family medicine providers, child and adolescent mental and behavioral health specialists, children's hospitals, and health facilities or programs operated by or in accordance with the Indian Health Service. The bill does not authorize new funding. Instead, it re-directs the use of existing grants under the SUPPORT Act. This means that while the scope of eligible activities and recipients for these grants would broaden, there is no new money entering the healthcare system as a direct result of this bill. The financial impact on healthcare providers would depend on their ability to secure these existing grants for the newly authorized purposes. Companies that offer services or facilities aligned with pediatric and young adult mental health and substance abuse prevention could see new revenue streams from these re-directed grants, but the overall market size for these grants remains unchanged. Companies such as Universal Health Services, Inc. ($UHS), which operates behavioral health facilities, and HCA Healthcare, Inc. ($HCA), which includes children's hospitals, could potentially benefit from the expanded eligibility for existing grants. Labcorp Holdings Inc. ($LH), Centene Corporation ($CNC), and Molina Healthcare, Inc. ($MOH) may also see indirect impacts through their healthcare service offerings or managed care plans that cover pediatric and young adult populations. However, the bill's early stage and lack of new funding temper any significant immediate market impact. Recent market data shows varied performance: $UHS is at $182.62 with a +2.04% 7-day change, $LH is at $274.49 with a +2.87% 7-day change, $HCA is at $486.5 with a +2.8% 7-day change, $CNC is at $35.83 with a +9.44% 7-day change, and $MOH is at $142.85 with a +7.16% 7-day change. All listed companies have shown positive 7-day changes, but their 30-day changes are mixed, with $UHS (-5.21%), $HCA (-8.69%), and $CNC (-17.92%) showing declines, while $LH (+1.78%) and $MOH (-1.12%) are relatively stable or slightly positive over 30 days. For the bill to progress, it must be considered and potentially marked up by the Energy and Commerce Committee and the Education and Workforce Committee. Following committee approval, it would need to pass the House, then be introduced and pass the Senate, and finally be signed into law by the President. Given its early stage and the lack of new funding, significant legislative hurdles remain, and its ultimate passage and impact are uncertain.